| Withdrawn | Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) Diphtheria Vaccine Adverse Reaction, Tetanus Vaccine Adverse Reaction, Pertussis Vaccine Adverse Reaction | Phase 3 | 2025-12-01 |
| Not Yet Recruiting | Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase I Vaccine Reaction, Vaccine Adverse Reaction | Phase 3 | 2025-09-01 |
| Not Yet Recruiting | Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV Antibody Typhoid Vaccine | — | 2025-06-15 |
| Not Yet Recruiting | Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Vaccine Adverse Reaction, Vaccine Reaction | Phase 1 / Phase 2 | 2025-03-01 |
| Completed | Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination COVID-19 | — | 2023-12-18 |
| Completed | Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine COVID-19 | Phase 2 | 2023-07-25 |
| Completed | Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Pat Safety Issues, Effect of Drug | Phase 4 | 2023-06-01 |
| Completed | Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age COVID-19 | Phase 2 | 2023-02-28 |
| Completed | Post Marketing Surveillance of Diphtheria Antitoxin (DAT) Safety Issues | Phase 4 | 2023-01-31 |
| Unknown | Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung Diabetes Mellitus, Type 2 | N/A | 2022-11-12 |
| Completed | Post Authorization Safety Study Moderna COVID-19 Primary Vaccine COVID-19 | — | 2022-11-03 |
| Completed | Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children Vaccine Reaction, Vaccine Adverse Reaction | Phase 3 | 2022-10-09 |
| Completed | Booster Study of COVID-19 Protein Subunit Recombinant Vaccine COVID-19 | Phase 2 | 2022-09-01 |
| Completed | Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine COVID-19 | Phase 3 | 2022-06-07 |
| Completed | Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine COVID-19 | Phase 2 / Phase 3 | 2022-04-13 |
| Completed | Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma) Human Papilloma Virus Infection | N/A | 2022-04-01 |
| Completed | Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018 COVID-19 | Phase 1 | 2022-02-16 |
| Completed | Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine Covid19 | Phase 1 | 2021-12-10 |
| Completed | Safety and Tuberculin Conversion Following BCG Vaccination BCG Vaccination Reaction | Phase 2 | 2021-12-01 |
| Completed | Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia Safety Issues | — | 2021-09-02 |
| Completed | Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian Vaccine | Phase 2 / Phase 3 | 2021-05-03 |
| Completed | Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates Rotavirus Gastroenteritis | Phase 3 | 2020-10-30 |
| Completed | Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombina Immunogenicity, Safety | Phase 3 | 2020-10-13 |
| Completed | Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine SARS-CoV2 Infection | Phase 3 | 2020-08-10 |
| Completed | Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III) Safety Issues, Immunogenicity | Phase 3 | 2020-03-02 |
| Completed | Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children Hepatitis B | Phase 1 | 2019-12-03 |
| Completed | Protectivity and Safety Following Recombinant Hepatitis B Vaccine Immunogenicity | Phase 2 / Phase 3 | 2019-09-11 |
| Completed | Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study) Congenital Rubella Infection, Measles | Phase 2 / Phase 3 | 2019-09-03 |
| Completed | Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and I Safety Issues, Immunogenicity | Phase 2 | 2018-07-16 |
| Completed | Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates Safety Issues | Phase 1 | 2018-04-09 |
| Completed | Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population Safety Issues | Phase 2 | 2017-11-21 |
| Completed | Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Safety Issues, Immunogenicity | Phase 4 | 2017-11-16 |
| Completed | Safety Profile Following Td Vaccination in Indonesian Pregnant Woman Healthy, Pregnant | — | 2017-08-29 |
| Completed | Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I) Safety Issues | Phase 1 | 2017-04-18 |
| Completed | Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV Healthy | Phase 4 | 2016-07-01 |
| Completed | Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study) Healthy | Phase 2 / Phase 3 | 2014-05-01 |
| Completed | Safety Profile Following Pentabio Vaccination in Indonesian Infants Healthy | — | 2014-05-01 |
| Completed | Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine Healthy | Phase 2 / Phase 3 | 2014-03-01 |
| Completed | Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma) Healthy | Phase 2 | 2013-05-01 |
| Completed | Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial Healthy | Phase 3 | 2012-08-01 |
| Completed | Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered Healthy | Phase 2 | 2011-07-01 |
| Completed | The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma) Healthy | Phase 1 | 2011-04-01 |
| Completed | Safety of Hib Vaccine (Bio Farma) Healthy | Phase 1 | 2010-11-01 |